# India pharma exports up 6.8% to $8.1 bn in Q1 FY27

2026-08-12T19:13:02+00:00 | Business & Economy | Indian Opinion Desk

Corroboration: 2 independent outlets

India's pharmaceutical exports rose 6.8% to $8.1 billion in the April-June quarter of FY27, driven by strong overseas demand for vaccines and bulk drugs, the Pharmaceuticals Export Promotion Council of India (Pharmexcil) said on Wednesday. Vaccine exports surged 35.68% to $390 million, the fastest growth segment, while bulk drugs and drug intermediates rose 13.84% to $1.36 billion. Drug formulations and biologicals, the largest category, grew 4.14% to $5.98 billion, accounting for nearly 74% of total pharma exports. The United States remained India's top country-level market with $2.5 billion in shipments, followed by Brazil, the UK, the Netherlands and France. NAFTA, Europe, Africa and Latin America together accounted for about 75% of exports. Pharmexcil chairman Namit Joshi said the sector combined scale in established markets with gains across wider geographies despite geopolitical turbulence.

## Coverage

- timesofindia.indiatimes.com <https://timesofindia.indiatimes.com/city/hyderabad/indias-pharmaceutical-exports-rise-6-8-in-q1-fy27-on-global-demand/articleshow/133187080.cms>
- hindustantimes.com <https://www.hindustantimes.com/india-news/indias-pharma-exports-grew-6-8-in-q1-fy27-pharmexcil-101786533694817.html>

Tags: generic drugs, pharma exports, Pharmexcil, US market, vaccines
Canonical: https://indianopinion.org/indias-pharma-exports-up-6-8-to-8-1-billion-in-q1/
License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources.
Cite: https://indianopinion.org/indias-pharma-exports-up-6-8-to-8-1-billion-in-q1/#story-in-brief

Review state: restored archive article, accurate at time of publication, not offered to search indexes.